Skip to main content
Premium Trial:

Request an Annual Quote

Cartagenia, Interactive Biosoftware Enter Software Integration Agreement

Premium

Cartagenia and Interactive Biosoftware have signed an agreement allowing Cartagenia to integrate IB's Alamut gene visualization software into its BenchLab, a web-based software tool for interpreting genomic variation in routine diagnostics.

The combined solution will merge BenchLab’s variant data filtering, interpretation, and management capabilities with Alamut’s annotation and visualization functionalities. It will let users assess candidate variants in context of phenotype as well as integrate their findings and conclusions with a lab or hospital’s laboratory information management system or electronic health record system.

Under the terms of the agreement, Cartagenia and IB will each market the combined solution to their respective customers, while continuing to sell their own products independently.

Andre Blavier, IB’s CEO, described the alliance between the two companies as a natural fit.

With the integration deal, “our Alamut solution is now extended with capabilities which were previously unavailable to us, such as patient database management, massively parallel variant filtering, and advanced lab reporting," Blavier said.

Furthermore, many BenchLab customers already use IB’s Alamut, Herman Verrelst, Cartagenia’s CEO, noted.

“The high level of automation and the lab-validated variant filtration pipelines in BenchLab are perfectly complemented by the Alamut gene browser that allows lab technicians to visualize specific variants of interest,” he said in a statement. “A technical integration of the two systems provides a single workflow experience.”

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.